ACOG Committee Opinion No. 357: Commercial enterprises in medical practice. Obstetrics and Gynecology 2007;109(1):243–5.
Applbaum K. Pharmaceutical marketing and the invention of the medical consumer. PLoS Medicine 2006;3(4):e189. Available at: http://medicine.plosjournals.org/archive/1549-1676/3/4/pdf/10.1371_journal.pmed.0030189-L.pdf.
Asai RG. What are my ethical obligations in enhancing my practice through marketing? Journal of the American Dental Association 2007;138(1):106–7.
Bear JC. “What's my DNA worth, anyway?”: a response to the commercialization of individuals' DNA information. Perspectives in Biology and Medicine 2004;47(2):273–89.
Beckman L. Are genetic self-tests dangerous? Assessing the commercialization of genetic testing in terms of personal autonomy. Theoretical Medicine and Bioethics 2004;25(5–6):387–98.
Breen KJ. The patient–doctor relationship in the new millennium: Adjusting positively to commercialism and consumerism. Clinics in Dermatology 2001;19(1):19–22.
Churchill LR. The United States health care system under managed care: How the commodification of health care distorts ethics and threatens equity. Health Care Analysis 1999;7(4):393–411.
Donohoe M. Luxury primary care, academic medical centers, and the erosion of science and professional ethics. Journal of General Internal Medicine 2004;19(1):90–4. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=14748866.
Donohue J. A history of drug advertising: The evolving roles of consumers and consumer protection. Milbank Quarterly 2006;84(4):659–99.
Elliott C. Pharma goes to the laundry: Public relations and the business of medical education. Hastings Center Report 2004;34(5):18–23.
Fugh-Berman A, Alladin K, Chow J. Advertising in medical journals: Should current practices change? PLoS Medicine 2006;3(6):e130. Available at: http://medicine.plosjournals.org/archive/1549-1676/3/6/pdf/10.1371_journal.pmed.0030130-L.pdf. Correction available at: http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030303.
Gilmartin MJ, Freeman RE. Business ethics and health care: A stakeholder perspective. Health Care Management Review 2002;27(2):52–65.
Granja M. [Dangerous liaisons—physicians and pharmaceutical sales representatives]. Acta Médica Portuguesa 2005;18(1):61–8. [ARTICLE in Portugese] Available at: http://www.actamedicaportuguesa.com/pdf/2005-18/1/061-068.pdf.
Hafferty F. Viewpoint: The elephant in medical professionalism's kitchen. Academic Medicine 2006;81(10):906–14.
Hoeyer K. The role of ethics in commercial genetic research: Notes on the notion of commodification. Medical Anthropology 2005;24(1):45–70.
Iltis AS. Stopping trials early for commercial reasons: The risk–benefit relationship as a moral compass. Journal of Medical Ethics 2005;31(7):410–4. Available at: http://jme.bmj.com/cgi/content/full/31/7/410.
Jagsi R. Conflicts of interest and the physician–patient relationship in the era of direct-to-patient advertising. Journal of Clinical Oncology 2007;25(7):902–5. Available at: http://jco.ascopubs.org/cgi/content/full/25/7/902.
Jerrold L, Karkhanehchi H. Advertising, commercialism, and professionalism: A history of the ethics of advertising in dentistry. Journal of the American College of Dentists 2000;67(4):39–44.
Kaveny MC. Commodifying the polyvalent good of health care. Journal of Medicine and Philosophy 1999;24(3):207–23.
Latham SR. Ethics in the marketing of medical services. Mount Sinai Journal of Medicine 2004;71(4):243–50. Available at: http://www.mssm.edu/msjournal/71/71_4_pages_243_250.pdf.
Lexchin J, Light DW. Commercial influence and the content of medical journals. British Medical Journal 2006;332(7555):1444–7. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1479665.
McArthur JH, Moore FD. The two cultures and the health care revolution. Commerce and professionalism in medical care. JAMA 1997;277(12):985–9.
McHenry L. On the origin of great ideas: Science in the age of big pharma. Hastings Center Report 2005;35(6):17–9.
Moynihan R. The marketing of a disease: Female sexual dysfunction. British Medical Journal 2005;330(7484):192–4. Available at: http://www.bmj.com/cgi/content/full/330/7484/192.
Moynihan R, Henry D. The fight against disease mongering: Generating knowledge for action. PLoS Medicine 2006;3(4):e191. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16597180.
Mykitiuk R. Caveat emptor: Direct-to-consumer supply and advertising of genetic testing. Clinical and Investigative Medicine 2004;27(1):23–32.
Olivieri NF. Patients' health or company profits? The commercialisation of academic research. Science and Engineering Ethics 2003;9(1):29–41.
Pellegrino ED. The commodification of medical and health care: The moral consequences of a paradigm shift from a professional to a market ethic. Journal of Medicine and Philosophy 1999;24(3):243–66.
Pinkus RL. From Lydia Pinkham to Bob Dole: What the changing face of direct-to-consumer drug advertising reveals about the professionalism of medicine. Kennedy Institute of Ethics Journal 2002;12(2):141–58.
Rajan KS. Genomic capital: Public cultures and market logics of corporate biotechnology. Science as Culture (London) 2003;12(1):87–121.
Relman AS. Profit and commercialism. In: Encyclopedia of bioethics. 3rd ed. New York: Macmillan Reference USA; 2004:2169–72.
Reuter L. The ethics of advertising strategies in the pharmaceutical industry. Ethics & Medicine 2003;19(3):171–5.
Schroeder C. The tyranny of profit: Concentration of wealth, corporate globalization, and the failed US health care system. Advances in Nursing Science 2003;26(3):173–84.
Scott IA. On the need for probity when physicians interact with industry. Internal Medicine Journal 2006;36(4):265–9.
Sillender M. Can patients be sure they are fully informed when representatives of surgical equipment manufacturers attend their operations? Journal of Medical Ethics 2006;32(7):395–7.
Smith R. Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Medicine 2005;2(5):e138. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1140949.
Southwick J. Ethics versus commercialism in the professions. Annals of the Royal Australasian College of Dental Surgeons 2000;15:264–7.
Steinbrook R. Commercial support and continuing medical education. New England Journal of Medicine 2005;352(6):534–5.
Steinbrook R. For sale: physicians' prescribing data. New England Journal of Medicine 2006;354(26):2745–7.
Stolberg HO. Yuppie scans from head to toe: Unethical entrepreneurism. Canadian Association of Radiologists Journal 2003;54(1):10–3.
Thompson A, Temple NJ. Ethics, medical research, and medicine: Commercialism versus environmentalism and social justice. Dordrecht: Kluwer Academic Publishers; 2001.
Tomycz ND. A profession selling out: Lamenting the paradigm shift in physician advertising. Journal of Medical Ethics 2006;32(1):26–8. Available at: http://jme.bmj.com/cgi/content/full/32126.
Tsai AC. Conflicts between commercial and scientific interests in pharmaceutical advertising for medical journals. International Journal of Health Services 2003;33(4):751–68.
Van Harrison R. The uncertain future of continuing medical education: Commercialism and shifts in funding. Journal of Continuing Education in the Health Professions 2003;23(4):198–209.
Wasson K, Cook ED, Helzlsouer K. Direct-to-consumer online genetic testing and the four principles: An analysis of the ethical issues. Ethics & Medicine 2006;22(2):83–91.
Weber DO. For sale: Body scans, boutique care & second opinions. Physician Executive 2003;29(2):10–6.
Werhane PH. Business ethics, stakeholder theory, and the ethics of healthcare organizations. Cambridge Quarterly of Healthcare Ethics 2000;9(2):169–81.
Wildes KW. More questions than answers: The commodification of health care. Journal of Medicine and Philosophy 1999;24(3):307–11.
Wolinsky H. Disease mongering and drug marketing. Does the pharmaceutical industry manufacture diseases as well as drugs? EMBO Reports 2005;6(7):612–4. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&blobtype=pdf&artid=1369125.
Yeo M. Marketing Rx&D: One step forward, two steps back. Canadian Medical Association Journal 2003;168(10):1273–4; discussion 4–5. Available at: http://www.CMAJ.ca/cgi/reprint/168/10/1273.
